AUS
NZ
UK
CA
USA
IND
-Copy_01_27_2025_20_08_39_516693.jpg)
Highlights
- Baxter International reduced its debt but still faces high liabilities.
- The company's EBIT growth of 36% in the last year supports debt management.
- Free cash flow of 53% of EBIT helps Baxter reduce its debt effectively.
Baxter International Inc has made significant strides in managing its debt while maintaining robust earnings growth. The company’s debt reduction and solid cash flow generation are key indicators of its financial health. However, its high liabilities still pose a potential risk. Baxter International Inc is part of NYSE Healthcare Stocks, making its financial performance crucial in the sector.
Understanding Baxter International's Debt Situation
Baxter International (NYSE:BAX) has a debt of $12.9 billion, a reduction from $16.5 billion over the past year. Despite having $1.42 billion in cash on hand, its net debt stands at $11.5 billion. The company’s liabilities, totaling $18.7 billion, significantly outweigh its cash and receivables of $3.2 billion, leaving a deficit of $15.5 billion. This raises concerns for shareholders, as a major capital raise could lead to dilution if the company needs to shore up its balance sheet.
Debt Management and Leverage Ratios
Baxter’s debt-to-EBITDA ratio stands at 4.2, while its earnings before interest and tax (EBIT) cover its interest expenses 4.5 times. These figures suggest that while the company is managing its debt levels, it does not have much room to take on additional debt. The company’s ability to handle its current leverage seems reasonable given its solid EBIT growth of 36% over the last 12 months.
Baxter’s Free Cash Flow as a Key Factor
One of the standout positives for Baxter is its ability to convert earnings into free cash flow. Over the past three years, the company has generated free cash flow equivalent to 53% of its EBIT. This means Baxter has the ability to reduce its debt using actual cash, which is essential for managing its liabilities and ensuring long-term financial stability.
Risks Related to Debt Levels
While Baxter’s high Return on Equity (14%) and solid Earnings Before Interest and Tax growth are positives, the company’s heavy reliance on debt remains a point of concern. With liabilities significantly higher than its cash and receivables, Baxter must remain cautious with its financial strategy. Despite its strong position in the medical equipment sector, the company’s debt levels could pose risks if it faces a financial downturn or struggles to generate sufficient cash flow.
A Balanced Approach to Debt
Baxter International's ability to handle debt remains manageable for now, thanks to its solid earnings performance and healthy cash flow. However, the company’s liabilities remain high relative to its available assets, which could expose it to greater risks if market conditions change. While Baxter’s robust earnings growth and free cash flow generation offer some reassurance, its significant debt load means shareholders must remain cautious.
